Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?

Archives of Gynecology and Obstetrics

Volumn 288, Issue 2, 2013, Pages 379-383

  Banz Jansen, Constanze ^a   Heinrichs, Alessa ^a   Hedderich, Marianne ^a   Waldmann, Annika ^b   Wedel, Berit ^a   Mebes, Imke ^a   Diedrich, Klaus ^a   Rody, Achim ^a   Fischer, Dorothea ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Breast cancer; Therapy; Treatment; Young patients

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GONADORELIN DERIVATIVE; PROGESTERONE RECEPTOR; TRASTUZUMAB;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST RECONSTRUCTION; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GERMANY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PREMENOPAUSE; PROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; FEMALE; GERMANY; HUMANS; LYMPHATIC METASTASIS; MAMMAPLASTY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENTINEL LYMPH NODE BIOPSY; YOUNG ADULT;

EID: 84880846898     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2738-7     Document Type: Article

References (19)

1. Robert Koch-Institut (Hrsg.) und Gesellschaft der epidemiologischen Krebsregister in Deutschland (Hrsg.) (2012): Krebs in Deutschland 2007/2008. 8. Ausgabe, Berlin
2. Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A (2009) Trends in hormone therapy and breast cancer incidence-results from the german network of cancer registries. Pathobiol 76:90-97
3. DeMichele A, Putt M, Zhang Y, Glick JH, Norman S (2003) Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 97:2150-2159
4. Kosiak B, Sangl J, Correa-de-Araujo R (2006) Quality of health care: what do we know? Women Health Issues 16:89-99
5. Banz-Jansen C, Heinrichs A, Hedderich M, Waldmann A, Dittmer C, Wedel B, Mebes I, Diedrich K, Fischer D (2012) Characteristics, therapy of premenopausal patients with early-onset breast cancer in Germany. Arch Gynecol Obstet 286(2):489-493
6. Disease-Management-Programme in Nordrhein Qualitätsbericht (2011) http://www.kvno.de/downloads/quali/qualbe-dmp11.pdf
7. Robles-Castillo J, Ruvalcaba-Limon E, Maffuz A, Rodriguez-Cuevas S (2011) Breast cancer in Mexican women under 40. Ginecol Obstet Mex 79(8):482-488
8. Kheirelseid EA H, Boggs JM, Curran C, Glynn RW, Dooley C, Sweeney KJ, Kerin MJ (2011) Younger age as a prognostic indicator in breast cancer: a cohort study. BMC Cancer 11:283
9. Tarone RE (2006) Breast cancer trends among young women in the United States. Epidemiology 17(5):588-590
10. Altekruse SF, Kosary CL, Krapcho M. (2010) SEER Cancer Statistics Review 1975-2007. In: Bethesda KD (eds) National Cancer Institute, based on November 2009 SEER data submissions, posted to the SEER web site, 2010. http://seer.cancer.gov/csr/1975-2007/, accessed November 5, 2010
11. Gonzales-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, Theriault R, Booser D, Buzdar AU, Hortobagyi GN, Arun B (2005) Women age < or =35 years with primary breast carcinoma: disease features at presentation. Cancer 103(12):2466-2472
12. Rapiti E, Fioretta G, Verkooijen HM, Vlastos G, Schäfer P, Sappino AP, Kurtz J, Neyroud-Caspar I, Bouchardy C (2005) Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer 41(10):1446-1452
13. Loibl S, Amant F, Kaufmann M, Ring A, Han S, Giermek J, Fehm T, Bontenbal M, Heinrigs M, Lenhard M, Scherr I, Mehta K, von Minckwitz G (2010) Patients with breast cancer during pregnancy-results from a prospective and retrospective registry (GBG20/BIG02-03). Cancer Res 70(24 Suppl):S2-S6
14. Colleoni M, Rormensz N, Robertson C, Orlando L, Viale G, Renne G, Luini A, Veronesi P, Intra M, Orecchia R, Catalano G, Galimberti V, Nolé F, Martinelli G, Goldhirsch A (2002) Very young women (<35 years) with operable breast cancer: features of disease presentation. Ann Oncol 13:273-279
15. El-Saghir NS, Seoud M, Khalil MK, Charafeddine M, Salem ZK, Geara FB, Shamseddine AI (2006) Effects of young age at presentation on survival in breast cancer. BMC Cancer 6:194
16. Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, Tulbah A, Al Malik O, Alshabanah M, Ezzat A, Al-Tweigeri T (2007) Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer 7:222
17. O'Shaughnessy J, Osborne C, Pippen JE, Yoffe M, Patt D, Rocha C, Koo IC, Sherman BM, Bradley C (2011) Iniparib plus chemotherapy in metastatic triple-negative breast cancer. N Engl J Med 364(3):205-214
18. de Bock GH, van der Hage JA, Putter H, Bonnema J, Bartelink H, van de Velde CJ (2006) Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European organisation for research and treatment of cancer studies. Eur J Cancer 42(3):351-356
19. Han W, Kim SW, Park IA, Kang D, Kim SW, Youn YK, Oh SK, Choe KJ, Noh DY (2004) Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer 4:82